Human glioma cell culture: Two FCS-free media could be recommended for clinical use in immunotherapy

In Vitro Cellular and Developmental Biology - Animal

Volumn 45, Issue 9, 2009, Pages 500-511

  Clavreul, Anne ^a,b   Jean, Isabelle ^a,b   Preisser, Laurence ^b,c   Chassevent, Agnès ^d   Sapin, Anne ^b   Michalak, Sophie ^a   Menei, Philippe ^a,b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c Service Commun de Cytométrie et d'Analyse Nucléotidique SCCAN   (France)

^d CENTRE PAUL PAPIN   (France)

Author keywords

Cell culture; Glioma; Immunotherapy; Tumour associated antigens

Indexed keywords

DNA; RECOMBINANT EPIDERMAL GROWTH FACTOR; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; ASTROCYTOMA; CANCER CELL CULTURE; CELL POPULATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; DNA CONTENT; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOTHERAPY; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIOMA; TUMOR BIOPSY;

ANTIGENS, NEOPLASM; BIOPSY; CANCER VACCINES; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CULTURE MEDIA, SERUM-FREE; DNA, NEOPLASM; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; IMMUNOTHERAPY; TUMOR CELLS, CULTURED;

EID: 70349311325     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-009-9215-4     Document Type: Article

References (61)

1. R. C. Anderson J. B. Elder M. D. Brown 2002 Changes in the immunologic phenotype of human malignant glioma cells after passaging in vitro Clin. Immunol. 102 84 95
2. D. D. Bigner S. H. Bigner J. Ponten 1981 Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas J. Neuropathol. Exp. Neurol. 40 201 229
3. D. D. Bigner O. M. Pitts C. J. Wikstrand 1981 Induction of lethal experimental allergic encephalomyelitis in nonhuman primates and guinea pigs with human glioblastoma multiforme tissue J. Neurosurg. 55 32 42
4. T. Bilzer D. Stavrou W. Wechsler 1991 Antigen variation in a human glioblastoma: from the primary tumor to the second recurrence, permanent cell line and xenotransplantation tumors Anticancer. Res. 11 547 553
5. V. Bocchini R. Casalone P. Collini 1991 Changes in glial fibrillary acidic protein and karyotype during culturing of two cell lines established from human glioblastoma multiforme Cell Tissue Res. 265 73 81
6. I. Borrello D. Pardoll 2002 GM-CSF-based cellular vaccines: a review of the clinical experience Cytokine Growth Factor Rev. 13 185 193
7. A. F. Carpentier Y. Meng 2006 Recent advances in immunotherapy for human glioma Curr. Opin. Oncol. 18 631 636
8. J. C. Chen Y. Chen J. M. Wu 2006 Effects of irradiated tumor vaccine and infusion of granulocyte-macrophage colony-stimulating factor and interleukin-12 on established gliomas in rats Cancer Immunol. Immunother. 55 873 883
9. D. D. Chi R. E. Merchant R. Rand 1997 Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas Am. J. Pathol. 150 2143 2152
10. M. H. Chun 2000 Serum signaling factors and spheroids Crit. Rev. Oncol. Hematol. 36 89 98
11. M. Colombatti B. Dipasquale L. Del-l'Arciprete 1989 Heterogeneity and modulation of tumor-associated antigens in human glioblastoma cell lines J. Neurosurg. 71 388 397
12. S. Das J. J. Raizer K. Muro 2008 Immunotherapeutic treatment strategies for primary brain tumors Curr. Treat Options Oncol. 9 32 40
13. C. Delaunay J. Honiger S. Darquy 1997 Bioartificial pancreas containing porcine islets of Langerhans implanted in low-dose streptozotocin-induced diabetic mice: effect of encapsulation medium Diabetes Metab. 23 219 227
14. M. Delhaye A. Clavreul E. Garcion 2003 Anti-glioma vaccination Neurochirurgie 49 459 463
15. O. Engebraaten R. Bjerkvig P. H. Pedersen 1993 Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain-tumour biopsies in vitro Int. J. Cancer 53 209 214
16. M. A. Farr-Jones I. F. Parney K. C. Petruk 1999 Improved technique for establishing short term human brain tumor cultures J. Neurooncol. 43 1 10
17. D. Frappaz S. E. Singletary G. Spitzer 1988 Enhancement of growth of primary metastatic fresh human tumors of the nervous system by epidermal growth factor in serum-free short term culture Neurosurgery 23 355 359
18. E. M. Hiesiger R. L. Hayes D. M. Pierz 1993 Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs) J. Neurooncol. 16 93 104
19. T. Imaizumi T. Kuramoto K. Matsunaga 1999 Expression of the tumor-rejection antigen SART1 in brain tumors Int. J. Cancer 83 760 764
20. W. C. Jean S. R. Spellman M. A. Wallenfriedman 2004 Effects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2, and interleukin-12 based immunotherapy against intracranial glioma in the rat J. Neurooncol. 66 39 49
21. N. Kadri N. Potiron M. Ouary 2007 Fetal calf serum-primed dendritic cells induce a strong anti-fetal calf serum immune response and diabetes protection in the non-obese diabetic mouse Immunol. Lett. 108 129 136
22. K. Kharbanda C. Sarkar A. K. Dinda 1993 Morphological appearance, growth kinetics and glial fibrillary acidic protein (GFAP) expression in primary in vitro explant culture of astrocytic neoplasms Acta. Oncol. 32 301 306
23. T. Kikuchi Y. Akasaki T. Abe 2004 Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12 J. Immunother. 27 452 459
24. T. Kikuchi Y. Akasaki M. Irie 2001 Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells Cancer Immunol. Immunother. 50 337 344
25. M. Kita M. M. Hanasono A. A. Mikulec 2006 Growth and growth factor production by human nasal septal chondrocytes in serum-free media Am. J. Rhinol. 20 489 495
26. V. Koka A. Potti S. E. Forseen 2003 Role of Her-2/neu overexpression and clinical determinants of early mortality in glioblastoma multiforme Am. J. Clin. Oncol. 26 332 335
27. J. Lee S. Kotliarova Y. Kotliarov 2006 Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines Cancer Cell 9 391 403
28. L. M. Liau R. M. Prins S. M. Kiertscher 2005 Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment Clin. Cancer Res. 11 5515 5525
29. G. Liu H. T. Khong C. J. Wheeler 2003 Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant glioma J. Immunother. 26 301 312
30. G. Liu H. Ying G. Zeng 2004 HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells Cancer Res. 64 4980 4986
31. D. M. Lonergan A. A. Mikulec M. M. Hanasono 2003 Growth factor profile of irradiated human dermal fibroblasts using a serum-free method Plast. Reconstr. Surg. 111 1960 1968
32. Y. H. Ma J. B. Yu H. P. Yao 2008 Treatment of intracerebral glioblastomas with G422 tumour cell vaccine in a mouse model J. Int. Med. Res. 36 308 313
33. A. Mackensen R. Drager M. Schlesier 2000 Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells Cancer Immunol. Immunother. 49 152 156
34. M. S. Mahaley Jr. D. D. Bigner L. F. Dudka 1983 Immunobiology of primary intracranial tumors. Part 7: Active immunization of patients with anaplastic human glioma cells: a pilot study J. Neurosurg. 59 201 207
35. Menei P.; Clavreul A.; Piard N. et al. Vaccination contre les gliomes malins par inoculation de cellules tumorales autologues et microperfusion locale de GM-CSF (étude de phase I). Proceeding of Société Francophone de Thérapie Cellulaire et Génique; 2002
36. K. Murayama T. Kobayashi T. Imaizumi 2000 Expression of the SART3 tumor-rejection antigen in brain tumors and induction of cytotoxic T lymphocytes by its peptides J. Immunother. 23 511 518
37. H. Okada L. Villa J. Attanucci 2001 Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells Gene. Ther. 8 1157 1166
38. F. Okano W. J. Storkus W. H. Chambers 2002 Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain Clin. Cancer Res. 8 2851 2855
39. I. F. Parney K. C. Petruk C. Zhang 1997 Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model Hum. Gene Ther. 8 1073 1085
40. P. H. Pedersen G. O. Ness O. Engebraaten 1994 Heterogeneous response to the growth factors [EGF, PDGF (bb), TGF-alpha, bFGF, IL-2] on glioma spheroid growth, migration and invasion Int. J. Cancer 56 255 261
41. I. F. Pollack M. S. Randall M. P. Kristofik 1990 Response of malignant glioma cell lines to epidermal growth factor and platelet-derived growth factor in a serum-free medium J. Neurosurg. 73 106 112
42. S. Rutkowski S. De Vleeschouwer E. Kaempgen 2004 Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study Br. J. Cancer 91 1656 1662
43. U. Sahin M. Koslowski O. Tureci 2000 Expression of cancer testis genes in human brain tumors Clin. Cancer Res. 6 3916 3922
44. S. Saikali T. Avril B. Collet 2007 Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy J. Neurooncol. 81 139 148
45. D. L. Scarcella C. W. Chow M. F. Gonzales 1999 Expression of MAGE and GAGE in high-grade brain tumors: a potential target for specific immunotherapy and diagnostic markers Clin. Cancer Res. 5 335 341
46. Shen F.; Mazumder M. A.; Burke N. A. et al. Mechanically enhanced microcapsules for cellular gene therapy. J. Biomed. Mater. Res. B Appl. Biomater (in press, July 2009).
47. S. Shimato A. Natsume T. Wakabayashi 2008 Identification of a human leukocyte antigen-A24-restricted T-cell epitope derived from interleukin-13 receptor alpha2 chain, a glioma-associated antigen J. Neurosurg. 109 117 122
48. K. E. Smith S. Janelidze E. Visse 2007 Synergism between GM-CSF and IFNgamma: enhanced immunotherapy in mice with glioma Int. J. Cancer 120 75 80
49. R. Stupp W. P. Mason M. J. van den Bent 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N. Engl. J. Med. 352 987 996
50. Vandesompele J.; De Preter K.; Pattyn F. et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3; 2002. RESEARCH0034
51. L. L. Vindelov I. J. Christensen N. I. Nissen 1983 A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis Cytometry 3 323 327
52. T. W. Vogel Z. Zhuang J. Li 2005 Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme Clin. Cancer Res. 11 3624 3632
53. D. G. Walker R. Laherty F. H. Tomlinson 2008 Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy J. Clin. Neurosci. 15 114 121
54. M. Warncke A. Dodero H. Dierbach 2006 Murine dendritic cells generated under serum-free conditions have a mature phenotype and efficiently induce primary immune responses J. Immunol. Methods 310 1 11
55. M. Westphal D. C. Hilt E. Bortey 2003 A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Neuro-oncol 5 79 88
56. M. Westphal H. Nausch H. D. Herrmann 1990 Antigenic staining patterns of human glioma cultures: primary cultures, long-term cultures and cell lines J. Neurocytol. 19 466 477
57. C. J. Wheeler K. L. Black G. Liu 2008 Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients Cancer Res. 68 5955 5964
58. R. Yamanaka 2008 Cell- and peptide-based immunotherapeutic approaches for glioma Trends Mol. Med. 14 228 235
59. R. Yamanaka J. Homma N. Yajima 2005 Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial Clin. Cancer Res. 11 4160 4167
60. J. S. Yu G. Liu H. Ying 2004 Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma Cancer Res. 64 4973 4979
61. J. G. Zhang J. Eguchi C. A. Kruse 2007 Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics Clin. Cancer Res. 13 566 575